Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.010 Biomarker group BEFREE High expression of p16 and Ki-67 or p16 alone favors the diagnosis of PBD over MSK. 30852607 2019
Entrez Id: 5347
Gene Symbol: PLK1
PLK1
0.010 Biomarker group BEFREE Particularly, hit-5, as a selective PLK1 inhibitor targeting PLK1-PBD, significantly inhibited the progression of HeLa cells-derived xenograft, with no obvious side effects. 31795214 2019
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.010 Biomarker group BEFREE High expression of p16 and Ki-67 or p16 alone favors the diagnosis of PBD over MSK. 30852607 2019
Entrez Id: 3295
Gene Symbol: HSD17B4
HSD17B4
0.010 Biomarker group BEFREE This depends largely on intact peroxisomal β-oxidation given the similarities in pathologies between peroxisome biogenesis disorders and deficiency of multifunctional protein-2 (MFP2), the central enzyme of this pathway. 29341299 2018
Entrez Id: 8086
Gene Symbol: AAAS
AAAS
0.010 GeneticVariation group BEFREE The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal matrix protein import. 28521612 2017
Entrez Id: 100329167
Gene Symbol: AAA1
AAA1
0.010 GeneticVariation group BEFREE The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal matrix protein import. 28521612 2017
Entrez Id: 351
Gene Symbol: APP
APP
0.010 GeneticVariation group BEFREE The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal matrix protein import. 28521612 2017
Entrez Id: 788
Gene Symbol: SLC25A20
SLC25A20
0.010 Biomarker group BEFREE We first analysed the effect of BTM on fatty acid beta-oxidation in fibroblasts derived from healthy controls as well as patients with X-ALD, mitochondrial carnitine-acylcarnitine translocase (CACT) deficiency, and peroxisome biogenesis disorder, Zellweger syndrome. 18470630 2008
Entrez Id: 7078
Gene Symbol: TIMP3
TIMP3
0.010 GeneticVariation group BEFREE We hypothesised that polymorphisms in TIMP-3 could affect susceptibility to IPF and PBD. 15223866 2004
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.010 GeneticVariation group BEFREE In this work, polymorphisms of the major histocompatibility complex (MHC) class II alleles and tumor necrosis factor alpha (TNF-alpha) promoter were evaluated in 44 patients with PBD, 99 healthy unrelated controls (HC), and 50 exposed but asymptomatic subjects (EAS). 11401868 2001
Entrez Id: 6783
Gene Symbol: SULT1E1
SULT1E1
0.010 GeneticVariation group BEFREE Eleven genes for PBDs have been identified either by a functional complementation cloning or by EST homology searches. 11405337 2001
Entrez Id: 1326
Gene Symbol: MAP3K8
MAP3K8
0.010 GeneticVariation group BEFREE Eleven genes for PBDs have been identified either by a functional complementation cloning or by EST homology searches. 11405337 2001
Entrez Id: 10046
Gene Symbol: MAMLD1
MAMLD1
0.010 GeneticVariation group BEFREE PEX1 mutation was delineated to be the genetic cause of PBD in the most highest incidence group, CG-E (the same as CG-I). 11330042 2000
Entrez Id: 3895
Gene Symbol: KTN1
KTN1
0.010 GeneticVariation group BEFREE PEX1 mutation was delineated to be the genetic cause of PBD in the most highest incidence group, CG-E (the same as CG-I). 11330042 2000
Entrez Id: 54566
Gene Symbol: EPB41L4B
EPB41L4B
0.010 GeneticVariation group BEFREE PEX1 mutation was delineated to be the genetic cause of PBD in the most highest incidence group, CG-E (the same as CG-I). 11330042 2000
Entrez Id: 11097
Gene Symbol: NUP42
NUP42
0.010 GeneticVariation group BEFREE PEX1 mutation was delineated to be the genetic cause of PBD in the most highest incidence group, CG-E (the same as CG-I). 11330042 2000
Entrez Id: 51268
Gene Symbol: PIPOX
PIPOX
0.010 AlteredExpression group BEFREE L-Pipecolic acid oxidase activity is deficient in patients with peroxisome biogenesis disorders (PBDs). 10642506 2000
Entrez Id: 472
Gene Symbol: ATM
ATM
0.010 AlteredExpression group BEFREE In this report we demonstrate that a portion of ATM co-localizes with catalase, that ATM is present in purified mouse peroxisomes, and that there are reduced levels of ATM in the post-mitochondrial membrane fraction of cells from a patient with a peroxisome biogenesis disorder. 10567403 1999
Entrez Id: 632
Gene Symbol: BGLAP
BGLAP
0.010 AlteredExpression group BEFREE Two daughters, 20- and 24-years-of-age, were discovered by study of his 5 children to have elevated serum ALP activity and OC levels and widespread PBD. 9193451 1997
Entrez Id: 54623
Gene Symbol: PAF1
PAF1
0.010 Biomarker group BEFREE The first, functional complementation, was established as a viable approach by Fujiki and colleagues, who identified PAF-1, the first known peroxisome biogenesis disorder gene. 8993569 1996
Entrez Id: 10085
Gene Symbol: EDIL3
EDIL3
0.010 Biomarker group BEFREE Three clonal abnormalities were seen as recurrent changes in 6 cases, namely interstitial deletions of 3p with 3p 12-14 as the minimally common deleted segment (in 1 papilloma, 1 diffuse PBD with atypia and 1 mixed-pattern lesion with both papilloma and atypical diffuse PBD features), r(9)(p24q34) (in 1 diffuse PBD and 1 fibroadenoma), and del(1)(q12)(again in 1 diffuse PBD and 1 fibroadenoma). 7814151 1995
Entrez Id: 3992
Gene Symbol: FADS1
FADS1
0.010 Biomarker group BEFREE The decrease in plasma arachidonate and the high tissue levels of LA suggest a defect of delta 6 desaturase and/or delta 5 desaturase in PB patients. 8177020 1994
Entrez Id: 847
Gene Symbol: CAT
CAT
0.020 Biomarker group BEFREE The absence of clear peroxisomal abnormalities in the patient's fibroblasts, including a normal peroxisomal localization of catalase, implies that even when all peroxisomal functions in fibroblasts are normal, a peroxisome biogenesis disorder cannot be fully excluded, and further studies may be needed. 15184617 2004
Entrez Id: 3000
Gene Symbol: GUCY2D
GUCY2D
0.020 Biomarker group BEFREE PEX6 is a causative gene for PBD of complementation group C (CG-C) and encodes the peroxin Pex6p, one of the ATPases associated with diverse cellular activities and a member of the same family of proteins as Pex1p, a causative protein for PBD of CG-E (CG1). 11004248 2000
Entrez Id: 3000
Gene Symbol: GUCY2D
GUCY2D
0.020 GeneticVariation group BEFREE PEX1 mutation was delineated to be the genetic cause of PBD in the most highest incidence group, CG-E (the same as CG-I). 11330042 2000